This year roughly 10,240 Idahoans will be diagnosed with cancer. Thanks in part to advances in cancer research and treatment, we are saving more lives than ever. But cancer remains a critical public health problem and getting new and affordable therapies from the research lab to the patient will require collaborative solutions from researchers, business leaders, health care providers and policymakers.
On Wednesday, September 15, the American Cancer Society Cancer Action Network (ACS CAN) will host a virtual policy forum to discuss some of these new research advances, cancer early detection efforts and the future of cancer care in Idaho. Join us for the event, Accelerating Innovations: Clinical Trials and Research, starting at 10 a.m. MDT.
Keynote speaker, Dr. Whitney Jones will highlight new technology that is currently being developed to detect multiple cancers early through a simple blood test. ACS CAN supports legislation in Congress that would create a pathway for Medicare coverage of these multi-cancer screening tests following FDA approval. The legislation (S 1873) is supported by Senator Mike Crapo, one of the lead bipartisan sponsors who introduced it in the U.S. Senate.
Additionally, a panel of speakers moderated by Jay Larsen of Idaho Technology Council will discuss cancer research taking place in Idaho as well as challenges and opportunities for cancer care in a rural state.
WHAT: ACS CAN Idaho Policy Forum, Accelerating Innovations: Clinical Trials and Research
WHEN: Wednesday, September 15, 2021 at 10 a.m. MDT
WHERE: RSVP at www.fightcancer.org/idaho. Registration closes on Tuesday, September 14 at Noon MDT.
WHO: Dr. Whitney Jones, gastroenterologist, adjunct professor at the University of Kentucky
Jay Larsen, founder and CEO, Idaho Technology Council
Dr. Krishna Alluri, oncologist and hematologist, St. Luke’s Cancer Institute
Dr. Carolyn Bohach, co-chair Idaho Bio Alliance of Medicine
Cheryl Adams, co-chair, Idaho Bio Alliance of Medicine